Premium
Disruption of Friend of GATA 2 gene ( FOG‐2 ) by a de novo t(8;10) chromosomal translocation is associated with heart defects and gonadal dysgenesis
Author(s) -
Finelli P,
Pincelli AI,
Russo S,
Bonati MT,
Recalcati MP,
Masciadri M,
Giardino D,
Cavagnini F,
Larizza L
Publication year - 2007
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.2007.00752.x
Subject(s) - chromosomal translocation , gonadal dysgenesis , biology , breakpoint , gene , phenotype , genetics , tetralogy of fallot , chromosome , fluorescence in situ hybridization , heart disease , medicine , endocrinology
FOG‐2 (Friend of GATA 2) is a transcriptional cofactor able to differentially regulate the expression of GATA‐target genes in different promoter contexts. Mouse models evidenced that FOG‐2 plays a role in congenital heart disease and normal testis development. In human, while FOG‐2 mutations have been identified in sporadic cases of tetralogy of Fallot, no mutations are described to be associated with impaired gonadal function. We here describe a young boy with a balanced t(8;10)(q23.1;q21.1) translocation who was born with congenital secundum‐type atrial septal defect and gonadal dysgenesis. Fluorescence in situ hybridization mapped the chromosome 8 translocation breakpoint (bkp) to within the IVS4 of the FOG‐2 gene, whereas the chromosome 10 bkp was found to lie in a desert gene region. Quantitative analysis of FOG‐2 expression revealed the presence of a truncated transcript but there was no detectable change in the expression of the genes flanking the 10q bkp, thus making it possible to assign the observed clinical phenotype to altered FOG‐2 expression. Genetic and clinical analyses provide insights into the signaling pathways by which FOG‐2 affects not only cardiac development but also gonadal function and its preservation.